Alcanza Clinical Research

Dr. Robert Molpus is Board Certified in Psychiatry well as Addiction Medicine with 34 years of clinical experience and Principal Investigator at CNS Healthcare for the past 17 years at both our Main Clinic and embedded Family Practice Clinic. He has successfully enrolled Pediatric, Adolescent, Adult, and Geriatric subjects in over 340 Ph I – IV clinical trials including Addiction, Cardiology, Dermatology, GI, Pain, Mood Disorders, Migraine, Women’s Health, Vaccine, Obesity, Diabetes, Hypertension, Psychiatry, Psychedelics and Sleep Disorders. Dr. Molpus has helped bring 108 drugs to market, with multiple clean FDA audits for high enrollment and no 483’s.

Dr. Molpus is a key thought leader and frequently collaborates with Sponsors and CROs on protocol design with a particular focus on addiction medicine. As the first Investigators to hold a Schedule I license for psychedelic trials, he has become a leader in this area and highly respected by Sponsors for his expertise.